Results 251 to 260 of about 409,260 (319)

192. Relation of image quality and administration dose of ^<123>I-IMP by triangular SPECT system

, 1991
Masato Yamada, Masamichi Matsudaira, Yoshinori Uoyama, Shinichi Ueda   +3 more
openalex   +2 more sources

Systematic review and meta‐analysis of the efficacy and safety of [177Lu]Lu‐edotreotide ([177Lu]Lu‐DOTATOC) for the treatment of neuroendocrine tumors

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
Abstract [177Lu]Lu‐edotreotide is a radiopharmaceutical therapy (RPT) targeting somatostatin receptors, which are commonly overexpressed on neuroendocrine tumors (NETs). This systematic literature review and meta‐analysis describes the efficacy and safety of [177Lu]Lu‐edotreotide in patients with NETs.
Richard P. Baum, Julia G. Fricke, Tristan Ruhwedel, Holger Amthauer, Erika Patricia Azorin‐Vega, Dieter Hörsch, Riccardo Laudicella, Vikalp Maheshwari, Martin A. Walter, Berna Degirmenci Polack, Simon F. Spiegl, Guillaume P. Nicolas   +11 more
wiley   +1 more source

75. A Study of Dual Energy Acquisition in Myocardial SPECT by T. E. W. (Triple energy window) Method

, 1994
Katsuya Sugimoto, Eiji Kidoya, Masato Tanaka, Hiroyuki Komuro   +3 more
openalex   +2 more sources

11C‐Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
Abstract Early detection of metastases and timely surgical intervention play a crucial role in the management of neuroendocrine tumors. In large‐sized pheochromocytomas and sympathetic paragangliomas (PPGL), functional imaging with positron emission tomography (PET) is recommended, as it improves the detection of metastases, which may go undetected on ...
Achyut Ram Vyakaranam, Olov Norlén, Alina Akural, Joakim Crona, Matilda Annebäck, Branislav Klimàcek, Peter Stålberg, Anders Sundin, Tobias Åkerström   +8 more
wiley   +1 more source

Investigation of Attenuation Correction Methods for Dual-Gated Single Photon Emission Computed Tomography (DG-SPECT). [PDF]

Bioengineering (Basel)
Rasel NM, Xing C, Zhou S, Yang Y, King MA, Jin M.   +5 more
europepmc   +1 more source

Optimization of collimator combinations for brain SPECT [PDF]

, 2010
Van Audenhaege, Karen
core  

Percutaneous Transluminal Angioplasty Can Facilitate Rehabilitation in Patient With Hemispatial Neglect: A Case Report

Neurology and Clinical Neuroscience, Volume 14, Issue 1, Page 85-88, January 2026.
ABSTRACT The superiority of percutaneous transluminal angioplasty (PTA) over maximal medical therapy for symptomatic intracranial artery stenosis in terms of secondary prevention has yet to be proved. However, several studies have reported that PTA can improve cortical symptoms and cognitive dysfunctions in selected patients with intracranial artery ...
Yoshitaka Nakamura, Masahiro Oomura, Hiroyasu Inoue, Rika Tsuboi, Noriyuki Matsukawa   +4 more
wiley   +1 more source

The role of multimodality imaging in selection, response assessment, and follow-up of patients receiving ¹⁷⁷Lutetium-PSMA-therapy. [PDF]

Insights Imaging
Ranjan A, Padden-Modi M, Abdel-Aty H, Galante J, Wan S, Maricar A, Adesina A, Drake B, Yusuf S, Cook G, James N, Adeleke S.   +11 more
europepmc   +1 more source

Osteitis Fibrosa Cystica: An Unusual Cause of Left‐Sided Chest Pain

Case Reports in Nephrology, Volume 2026, Issue 1, 2026.
We report a case of osteitis fibrosa cystica resulting from secondary hyperparathyroidism in a 21‐year‐old male patient with end‐stage renal disease. The patient presented with persistent, moderate chest pain localized to the left fifth and sixth ribs for eight months. A chest X‐ray revealed well‐defined, expansile lytic lesions in these ribs.
Raahima Habib, Maha Anjum, Ayesha Mahmood, Nabiha Rizvi, Poulami Jha   +4 more
wiley   +1 more source

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

International Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu, Luqiang Wang, Xuelian Zhang, Suraiya Saleem   +3 more
wiley   +1 more source